Shanghai Municipal Science and Technology Commission Surveys Bioyitech: Building the "Chinese Core" of the Probiotic Industry, Assisting in the "Prevention and Treatment" of Metabolic Diseases

•Municipal Science and Technology Commission Surveys Bioyitech

•Building the "Chinese Core" of the Probiotic Industry

•Assisting in the "Prevention and Treatment" of Metabolic Diseases

On the afternoon of July 22nd, Hu Guangjing, Director of the Life Science and Technology Department of the Shanghai Municipal Science and Technology Commission, and Zhang Xuebo from the Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, visited Jinhui Town, Fengxian District, for a special survey of Bioyitech (Shanghai) Biotechnology Co., Ltd. They engaged in in-depth discussions around "how a probiotic can be made into an industrial chain and a health defense line." Relevant leaders from the District Economic Commission, District Science and Technology Commission, the Beautiful Health Special Team, and Jinhui Town accompanied the survey.

I. From -80°C to Hundred-Grade Cleanliness: The Birth of a "Chinese Strain"

In Bioyitech's "Strain Bank," over 6,000 preserved strains and 102 functional Probiotics are neatly arranged; among them, the GLP-1 targeted "Simei bacteria" has completed clinical research on blood sugar and blood lipids in collaboration with top-tier hospitals. The survey team visited the 4,300㎡ intelligent production workshop on-site, observing the probiotic "hundred-grade clean workshop," where the "trillion-level high-density culture & micro-ice crystal freeze-drying" process increases the survival rate of live probiotics by 30%（ ( Bifidobacterium animalis subsp. Lactis F1-7 , Lactiplantibacillus plantarum F3-2). Director Hu Guangjing praised, "This is the 'Chinese core' of the probiotic industry!"

II.Symposium: Three "Report Cards" and Three "New Demands"

At the symposium, Bioyitech Chairman Li Jiadong reported on the full-chain innovation of "scientific research—industry—market":

Scientific Research Report Card

•Built a proprietary strain library of 6,000 strains, with 102 functional probiotics;

•In 2024, R&D investment accounted for 33%, and the GLP-1 targeted "Simei bacteria" entered clinical trials;

•Has obtained 9 core patents and 5 international certifications, achieving the export of "Chinese strains" to Western Europe and Southeast Asia.

Industrial Report Card

•Reached ODM business cooperation with top brands such as Bright Dairy and Tongrentang;

•The first phase of the Fengxian factory's 5 production lines are operating at full capacity;

•The Chongqing Jiangjin fermentation factory and the Shenyang probiotic laboratory will be put into operation within the year, accelerating the formation of the "Shanghai R&D + national production capacity" pattern.

Market Report Card

•Postbiotics, fermented fruits and vegetables, and other new categories were launched at international exhibitions such as NHNE and Vitafoods;

•Won 7 industry awards, including the iSEE Global Top 100 and the Nutrition Box "Intestinal Health Explosive Product Award."

Subsequently, the company put forward three new demands:

① Include the Probiotic Industry Research Institute in the municipal major innovation platform;

② Connect with Shanghai municipal hospital resources for clinical validation of chronic diseases;

③ Provide policy guidance on overseas registration and cross-border fund settlement.

"I didn't expect that behind a small probiotic, there was a 30-year scientific research persistence." After Chairman Li Jiadong introduced that Professor Zhang Lanwei's team has been deeply involved in the field of probiotics for 30 years, Zhang Xuebo from the Chinese Academy of Sciences exclaimed, "This is a perfect combination of the spirit of scientists and the spirit of entrepreneurs!"

In the next step, the district and town levels will link with the Municipal Science and Technology Commission to enable "Chinese strains" to go from Fengxian to the world, contributing "Chinese innovation power" to the construction of Shanghai's global science and technology innovation center.